Return to program book search
Advances in Psoriasis
Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.
Friday, March 16
7:15 AM - 8:45 AM
Jeffrey M. Weinberg, MD, FAAD - Handout
Following this course, the attendee will be able to:
- Assess the latest efficacy and safety data for current biologic therapies for psoriasis
- Assess the latest efficacy and safety data for topical, oral, and biologic therapies in development for psoriasis
- Discuss the latest information regarding the pathophysiology and comorbidities of psoriasis
Over the last decade, we have witnessed great advances in the understanding and treatment of psoriasis. These advances have included new topical and biologic therapies, as well as an increased understanding of the systemic sequelae of this condition. During this session, the latest efficacy and safety data for current biologic therapies and therapies in development for psoriasis will be reviewed. An update on the pathophysiology and comorbidities of psoriasis will also be presented.